Article
KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer.
The Journal of molecular diagnostics : JMD - 1 Jan 2010
Franklin Wilbur A, Haney Jerry, Sugita Michio, Bemis Lynne, Jimeno Antonio, Messersmith Wells A
Abstract excerpt
Treatment of colon carcinoma with the anti-epidermal growth factor receptor antibody Cetuximab is reported to be ineffective in KRAS-mutant tumors. Mutation testing techniques have therefore become an urgent concern. We have compared three methods for detecting KRAS mutations in 59 cases of colon carcinoma: 1) high resolution melting, 2) the amplification refractory mutation system using a bifunctional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
